Scientific Abstracts dently (dcSSc: P=3.20E-2, OR=1.13; PAH: P=2.19E-02, OR=1.32). However, our data revealed a stronger effect size with the subset of SSc patients showing both clinical manifestations (dcSSc with PAH: P=6.91E-3, OR=2.05).
Background: Systemic lupus erythematosus (SLE) is a complex polygenic autoimmune disease, characterized by autoantibody production, inflammatory manifestation and imbalanced cytokine production. In accordance with the pivotal role of Th17 cell in autoimmunity and the altered Th17/Tregs balance in response to changes in the cytokine milieu we analyzed mRNA expression of several cytokines in peripheral blood of SLE patients. Quantification of mRNA expression in peripheral blood could be useful to assess the disease activity of SLE patients. Objectives: The aim of the present study was to investigate the gene expressions at mRNA level of proinflammatory (TNFA, IL18, IL12B); Th17-related (IL23A); immunosuppressive (TGFB1 and IL10) cytokines and Treg-specific transcription factor Foxp3 in peripheral blood of women with SLE. Methods: Total RNA from peripheral blood was isolated from 28 female patients with SLE and 17 healthy women. Quantitative real-time polymerase chain reaction was performed for 7 genes of interests, using the TaqMan detection system. Relative quantitative evaluation of mRNAs was performed by the comparative Ct method and results are presented as n-fold mean difference (RQ-relative quantity) of target genes relative to calibrator (healthy controls) after normalization to the reference gene-GAPDH. Disease activity in SLE was determined by SLEDAI and divided into three categories: mild (0-5), moderate (6-10) and high (>10).
Results:
The results reveal considerable overexpression of IL23A in SLE patients compared to healthy controls (RQ=5.347; p<0.001). According to the level of disease activity we found the highest elevation of IL23A in patients with SLEDAI>10 (RQ=8.54; p<0.001) compared to the controls. In inactive to mild (SLEDAI 0-5) and moderate SLE (SLEDAI 6-10), IL23A was also upregulated in approximately equal rate (RQ=4.976; p<0.001 and RQ=4.64; p<0.001). In addition, immunosuppressive cytokines IL10 and TGFB1 mRNA were elevated significantly in SLE patients than in controls (RQ=1.79; p=0.0077 and RQ=1.78; p=0.02, respectively). We also found that the expression of proinflammatory TNFA and IL12B were significantly downregulated approximately 2-fold. The mRNA level of Foxp3 was downregulated only for patients with SLEDAI>10. A significant good correlation between IL18 and the SLEDAI score was found (r=0.5548; p=0.002). Higher IL18 expression was observed among patients with worsened SLE compared to those with mild (RQ=1.656; p=0.008) and moderate (RQ=1.474; p=0.034) disease activity. We further demonstrated positively correlation between the expression levels of IL23A and TGFB1 (r=0.7276; p<0.001) among SLE patients. Conclusions: These results suggest that upregulation of IL23 and TGFB1 in addition to downregulated Foxp3 expression may contribute to skewing towards Th17 profile in SLE pathogenesis and this was the most markedly manifested at the highest level of disease activity. Our results support indirectly the idea for restoring Th17/Treg balance as a therapeutic target in SLE. Background: Behçet Disease (BD) is a relapsing inflammatory autoimmune disease. Although the etiology of BD is not yet known, genetic predisposition and immune dysregulation are thought to be critical factors in the pathogenesis of the disease. MicroRNAs (miRNAs) are small RNA fragments that can regulate the gene expression. miRNAs play a critical role in the pathogenesis of autoimmune or auto inflammatory diseases. Sinngle nucleotide polymorphisms (SNPs) may change the property of miRNAs through altering miRNA expression and/or maturation. Objectives: The aim of this work was to detect miRNA-499 (rs3746444) genotyping and relative expression in BD patients in order to find out the possible association between them and disease activity and severity. Methods: Relative expression of miRNA-499 was measured by Real-Time PCR and miRNA-499 gene (rs 3746444) genotyping was performed by TaqMan SNP Genotyping Assay in blood samples obtained from 47 patients BD diagnosed according to 1990 international criteria for behcet disease and 50 matched healthy controls. Disease activity was done using BD current activity form (BDCAF). Results: Study of miRNA-499 polymorphism, showed that the genotype frequencies of TT, CT, and CC were 21.3%, 63.8%, and 14.9% in BD patients and 18.0%, 52.0%, and 30.0% in the control group respectively. A significant increase in the relative expression of miRNA-499 was found in BD patients compared to control (P<0.05). There was no significant relation between relative expression of miRNA-499 and activity of BD patients assessed by BDCAF (P>0.05). In addition there was association between genotypes of miRNA-499 and posterior uveitis (P<0.05). There was association of the relative expression of miRNA-499 with miRNA-499 (rs3746444) polymorphism and vascular manifestations (P<0.05). Conclusions: Genotyping of miRNA-499 showed higher percentage of TT genotype in BD patients than control and also miRNA relative expession, they may be implicated in pathogenesis of the disease. Genotype TT for miRNA-499 is associated with posterior uveitis. miRNA relative expression is associated with vascular manifestations and aneurysm. Background: Despite its high prevalence and mortality, little is known about the pathogenesis of RA-associated interstitial lung disease (RA-ILD). Given that familial pulmonary fibrosis (FPF) and RA-ILD frequently share the usual interstitial pneumonia pattern and common environmental risk factors, we hypothesized that the two diseases may share additional risk factors including FPF-linked genes. Objectives: Our aim was to identify coding mutations of FPF-risk genes associated with RA-ILD. Methods: We used whole-exome sequencing (WES) followed by restricted analysis of a discrete number of FPF-linked genes and performed a Burden test to assess the excess number of mutations in RA-ILD patients compared to controls. Results: Among the 101 RA-ILD patients included, 12 (11.9%) had 13 WESidentified heterozygous mutations in the TERT, RTEL1, PARN or SFTPC coding regions. The burden test, based on 81 RA-ILD patients and 1010 controls of European ancestry, revealed an excess of TERT, RTEL1, PARN or SFTPC mutations for RA-ILD patients (p=9.45'10 -4 , odds ratio [OR] 3.17 95% CI 1.53-6.12). Telomeres were shorter for RA-ILD patients with a TERT, RTEL1 or PARN mutation than controls (p=2.87x10 -2 ). Conclusions: Our results support the contribution of FPF-linked genes to RA-ILD susceptibility. Disclosure of Interest: None declared DOI: 10.1136/annrheumdis-2017-eular.5237
